Medicus Pharma Lt…
USUSDMedicus Pharma Ltd. (US:MDCX) — Biotechnology: Pharmaceutical Preparations. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 1. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site Web
- medicuspharma.com
- Relations avec les Investisseurs
- medicuspharma.com/investor-relations/press-releases/
- Secteur
- Health Care · Biotechnology: Pharmaceutical Preparations
- Siège Social
- W. CONSHOHOCKEN, United States
- PDG
- Raza Bokhari
- Employés
- 16
- Actions en Circulation
- 63.18 M au 2026-08-10
- Flottant
- 52.61 M
- Capitalisation Boursière
- 138 068 USD
- Initiés
- 22.6%
- Investisseurs Institutionnels
- 4.15%
- Secteur d'Activité (SIC)
- Pharmaceutical Preparations
- P/E
- perte
- FCF
- −29.3 M USD
- Dette
- ?
- Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
- NAV
Description
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. The company has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in West Conshohocken, Pennsylvania.
Bourses et Tickers
| Bourse | Ticker | Devise | Prix | Type |
|---|---|---|---|---|
| US USA Stocks | MDCX | USD | 3.12 -4.88% | actions ordinaires |
Principaux Actionnaires
| Détenteur | Participation | Actions | Date du Rapport |
|---|---|---|---|
| BOKHARI RAZA (Chief Exec… | ≈4.65% | 2.94 M | 2026-09-04 |
| Interchange Capital Part… | 2.51% | 1.59 M | 2026-06-30 |
| BONNER CAROLYN F (Presid… | ≈2.36% | 1.49 M | 2026-09-04 |
| MEHMUD FAISAL M.D. (Offi… | ≈2.33% | 1.47 M | 2026-09-04 |
| SMITH ANDREW ALASDAIR (C… | ≈1.16% | 735 458 | 2026-09-04 |
| BRENNAN EDWARD JOSEPH JR… | ≈1.07% | 674 735 | 2026-09-04 |
| QUINLAN JAMES P (Chief F… | ≈0.84% | 528 294 | 2025-08-13 |
| Jane Street Group, LLC | 0.53% | 333 673 | 2026-06-30 |
| Xtx Topco Ltd | 0.39% | 243 362 | 2026-06-30 |
| Sterling Investment Advi… | 0.16% | 100 000 | 2026-06-30 |
| Commonwealth Equity Serv… | 0.08% | 52 643 | 2026-06-30 |
| May Hill Capital, LLC | 0.08% | 50 622 | 2026-06-30 |
| Susquehanna Internationa… | 0.05% | 31 462 | 2026-06-30 |
| Stifel Financial Corpora… | 0.05% | 30 000 | 2026-06-30 |
| Wilmington Savings Fund… | 0.04% | 25 622 | 2026-06-30 |
| JPMORGAN CHASE & CO | 0.04% | 25 622 | 2026-06-30 |
| EQ Advisors Trust-1290 V… | 0% | 2 737 | 2026-03-31 |
| VELOCITY FUND PARTNERS,… | — | — | 2025-05-20 |
